Have we been progressing spermsep during this time? Are we years...

First 6 Last

Share
Profile

Follow
Gaffa Lodge

204 Posts.

7

04/03/17

11:33

Post #: 23096951
Share

Originally posted by Michelin Man ↑

Good morning Kosenar,
Great to see you posting here again. Hopefully one day you may persuaded to put your toe back in the water with MEM.
BTAIM I am sure your fears are unfounded. There is no way Alison (and Andrew from what I hear) would ever entangle themselves with JM or HN again. I think the key part of the ANN is:
Crescendas Projects Pte Ltd is part of the group of companies controlled by Crescendas Pte Ltd, a private Singapore conglomerate. Crescendas Pte Ltd is the major shareholder of JP Asia Prime Capital (Pte.) Ltd ((“JP”), which is the co-investor alongside Pulau Manukan Ventures Labuan Ltd (“Manukan) in PrIME Biologics Pte Ltd (“PrIME”). JP holds a substantial number of A class voting shares in PrIME.
In earlier posts I have speculated that other key investors apart from Manukan must be getting tired of the slow progress at PrIME, little to show for the millions they have invested since the spin out, the litigation (not just the expense but the time and energy wasted) and "the silly games" e.g. claiming ownership of the machine which they previously paid us rent for! I suspect these other investors may be using this as a way of telegraphing to our adversaries that we are not going to run out of money before the arbitration is finalized in the next 12 months or so and that they had better negotiate realistically if they don't want to run the risk of a huge embarrasment if the arbitration runs its course.
The only downside I see for us is that our own plans are largely on hold until we can finally put the PrIME debacle behind us.....but I am increasingly confident of the outcome. I really think the arbitation will be a big win for us if it proceeds...and that's why I think the case will probably settle. However one possible downside with this ANN is that the other PrIME investor might put (understandable) pressure on us to settle low and release our B shares for less than they are really worth. Who knows even this approach may be worth it if we can get on with our own program....but the cheaper we let go of the Bs the more lilely there will need to be capital raised and for this reason I hope our Board can now negotiate from a position of relative strength.
GLTA
Kind regards,

Expand

Have we been progressing spermsep during this time? Are we years behind where we should be? Is the machine still cutting edge? Is the 6.8 million dollars or so best spent taking this possibly out dated machine to market? Do we have any updates on that although I know we can't have the cart before the horse. Still a lot to think about in this company.. It's going to be a very interesting 12 months ahead.

MEM Price at posting: 0.4¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MLS

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 13 more messages in this thread...

First 6 Last

Add MEM (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $13.00M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$25.15K	5.030M

Buyers (Bids)

No.	Vol.	Price($)
14	18291263	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	8551662	3

View Market Depth

No.	Vol.	Price($)
2	60206	0.024
1	14090	0.022
3	497619	0.021
5	649700	0.020
2	130000	0.018

Price($)	Vol.	No.
0.025	153799	6
0.037	18526	1
0.039	1200000	1
0.046	100000	1
0.047	1160000	3

Last trade - 10.32am 08/11/2024 (20 minute delay)

MEM (ASX) Chart

Have we been progressing spermsep during this time? Are we years...

Top Stories

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Universal Biosensors flat despite fresh deal with US medical product distributor

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Buyers (Bids)

Sellers (Offers)